Medical Dialogues7 小时
Upadacitinib Shows Long-Term Success in the Treatment of Atopic Dermatitis, finds study
A recent study published in the Dermatology and Therapy journal confirmed the effectiveness and safety of upadacitinib, a ...
Nektar receives FDA Fast Track Designation for rezpegaldesleukin
Therapeutics announced that the U.S. FDA has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and ...
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment ...
Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of adult and pediatric ...